Vascular Oxidative Stress: The Common Link in Hypertensive and Diabetic Vascular Disease
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Vascular disease in hypertension and diabetes is associated with increased oxidants. The oxidants arise from NADPH oxidase, xanthine oxidase, and mitochondria. Superoxide anion and hydrogen peroxide are produced by both leukocytes and vascular cells. Nitric oxide is produced in excess by inducible nitric oxide synthase, and the potent oxidant, peroxynitrite, is formed from superoxide and nitric oxide. The damage to proteins caused by oxidants is selective, affecting specific oxidant-sensitive amino acid residues. With some important vascular proteins, for example, endothelial nitric oxide synthase, prostacycline synthase, and superoxide dismutase, oxidation of a single susceptible amino acid inactivates the enzyme. The beneficial effects of antioxidants, at least in animal models of hypertension and diabetes, can in part be ascribed to protection of these and other proteins. Mutant proteins lacking their reactive constituent can recapitulate some disease phenotypes suggesting a pathogenic role of the oxidation. Thus, many of the shared functional abnormalities of hypertensive and diabetic blood vessels may be caused by oxidants. Although studies using antioxidants have failed in patients, the successful treatment of vascular disease with HMG-CoA reductase inhibitors, thromboxane A2 antagonists, and polyphenols may depend on their anti-inflammatory effects and ability to decrease production of damaging oxidants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063 · cited 1×
“The worldwide morbidity of diabetes mellitus has increased rapidly even in developing countries, doubling the combined risk of cardiovascular events in patients with hypertension.(2,3) The endothelium is the principal target of cardiovascular risk factors, including hypertension and diabetes, and is the cell most invo…”
BackgroundNAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765 · cited 1×
“Xanthine oxidase is also a source of ROS in atherosclerosis and has been implicated in hypertension and diabetes.(51,52) Some of the therapeutic effects of allopurinol used to control uric acid levels in many patients with hypertension and diabetes may result from inhibiting this enzyme.”
BackgroundFunctional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases
Martyn, K. D., Frederick, L. M., von Loehneysen, K., Dinauer, M. C., & Knaus, U. G. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.023 · Cited by 783
Touyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., & Schiffrin, E. L. (2002) · Circulation Research · doi:10.1161/01.res.0000020404.01971.2f · Cited by 590 · cited 1×
“NADPH oxidase is the primary source of ROS in the vasculature and is functionally active in all cells within the vessel wall, including endothelial cells, VSMCs, fibroblasts, and monocytes/macrophages.(10,11) NADPH oxidase is a multicomponent enzyme that is comprised of membrane components p22phox and gp91phox (termed…”
BackgroundAscorbic Acid Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
Levine, G. N., Frei, B., Koulouris, S. N., Gerhard, M. D., Keaney, J. F., & Vita, J. A. (1996) · Circulation · doi:10.1161/01.cir.93.6.1107 · Cited by 582
p22phox mRNA Expression and NADPH Oxidase Activity Are Increased in Aortas From Hypertensive Rats
Fukui, T., Ishizaka, N., Rajagopalan, S., Laursen, J. B., Capers, Q., Taylor, W. R., Harrison, D. G., de Leon, H., Wilcox, J. N., & Griendling, K. K. (1997) · Circulation Research · doi:10.1161/01.res.80.1.45 · Cited by 553
Ambasta, R. K., Kumar, P., Griendling, K. K., Schmidt, H. H. H. W., Busse, R., & Brandes, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406486200 · Cited by 541
Research works printed but not linked: 79
- Contreras, 2000, J Hum Hypertens, 14, S26, 10.1038/sj.jhh.1000983 · DOI
- Savoia, 2006, Curr Diab Rep, 6, 274, 10.1007/s11892-006-0060-5 · DOI
- Adachi, 2005, Drug Discov Today, 2, 39, 10.1016/j.ddmec.2005.05.022 · DOI
- Adachi, 2004, J Biol Chem, 279, 29857, 10.1074/jbc.M313320200 · DOI · Paper page
- Clavreul, 2006, FASEB J, 20, 518, 10.1096/fj.05-4875fje · DOI · Paper page
- Adachi, 2004, Nat Med, 10, 1200, 10.1038/nm1119 · DOI · Paper page
- Ying, 2007, Arterioscler Thromb Vasc Biol, 27, 783, 10.1161/01.ATV.0000258413.72747.23 · DOI · Paper page
- Ellmark, 2005, Cardiovasc Res, 65, 495, 10.1016/j.cardiores.2004.10.026 · DOI · Paper page
- Meng, 2008, Cardiovasc Res, 80, 299, 10.1093/cvr/cvn173 · DOI · Paper page
- Touyz, 2004, Histochem Cell Biol, 122, 339, 10.1007/s00418-004-0696-7 · DOI · Paper page
- Touyz, 2003, Curr Opin Nephrol Hypertens, 12, 165, 10.1097/00041552-200303000-00007 · DOI
- Schiffrin, 2004, Am J Physiol Heart Circ Physiol, 287, H435, 10.1152/ajpheart.00262.2004 · DOI · Paper page
- Lassegue, 2003, Am J Physiol Regul Integr Comp Physiol, 285, R277, 10.1152/ajpregu.00758.2002 · DOI · Paper page
- Pagano, 1995, Am J Physiol, 268, H2274
- Wang, 1998, Circ Res, 82, 810, 10.1161/01.RES.82.7.810 · DOI · Paper page
- Wang, 1999, Hypertension, 33, 1225, 10.1161/01.HYP.33.5.1225 · DOI · Paper page
- Seshiah, 2002, Circ Res, 91, 406, 10.1161/01.RES.0000033523.08033.16 · DOI · Paper page
- Rajagopalan, 1996, J Clin Invest, 97, 1916, 10.1172/JCI118623 · DOI · Paper page
- Privratsky, 2003, Hypertension, 42, 206, 10.1161/01.HYP.0000082814.62655.85 · DOI · Paper page
- Ghiadoni, 2003, Hypertension, 41, 1281, 10.1161/01.HYP.0000070956.57418.22 · DOI · Paper page
- Wang, 2001, Circ Res, 88, 947, 10.1161/hh0901.089987 · DOI · Paper page
- Jung, 2004, Circulation, 109, 1795, 10.1161/01.CIR.0000124223.00113.A4 · DOI · Paper page
- Zhou, 2006, Hypertension, 47, 81, 10.1161/01.HYP.0000197182.65554.c7 · DOI
- Haurani, 2007, Cardiovasc Res, 75, 679, 10.1016/j.cardiores.2007.06.016 · DOI · Paper page
- Landmesser, 2002, Hypertension, 40, 511, 10.1161/01.HYP.0000032100.23772.98 · DOI · Paper page
- Williams, 1998, Circulation, 97, 1695, 10.1161/01.CIR.97.17.1695 · DOI · Paper page
- Rask-Madsen, 2007, Nat Clin Pract Endocrinol Metab, 3, 46, 10.1038/ncpendmet0366 · DOI · Paper page
- Quagliaro, 2005, Atherosclerosis, 183, 259, 10.1016/j.atherosclerosis.2005.03.015 · DOI · Paper page
- Liu, 2007, Free Radic Biol Med, 42, 852, 10.1016/j.freeradbiomed.2006.12.025 · DOI
- Guzik, 2002, Circulation, 105, 1656, 10.1161/01.CIR.0000012748.58444.08 · DOI · Paper page
- Lopez-Lopez, 2008, Am J Physiol Lung Cell Mol Physiol, 295, L727, 10.1152/ajplung.90354.2008 · DOI
- Ulker, 2004, Diabetes Obes Metab, 6, 442, 10.1111/j.1462-8902.2004.00443.x · DOI
- Vecchione, 2006, Circ Res, 98, 218, 10.1161/01.RES.0000200440.18768.30 · DOI
- Wei, 2007, Hypertension, 50, 384, 10.1161/HYPERTENSIONAHA.107.089284 · DOI · Paper page
- Molnar, 2005, Circ Res, 96, 1178, 10.1161/01.RES.0000168634.74330.ed · DOI · Paper page
- Matsumoto, 2003, Free Radic Res, 37, 767, 10.1080/1071576031000107344 · DOI · Paper page
- Cohen, 1993, Circulation, 87, V67
- Yang, 2002, Br J Pharmacol, 136, 104, 10.1038/sj.bjp.0704669 · DOI · Paper page
- Yang, 2003, Hypertension, 41, 143, 10.1161/01.HYP.0000047651.45322.16 · DOI · Paper page
- Yang, 2004, Fundam Clin Pharmacol, 18, 321, 10.1111/j.1472-8206.2004.00247.x · DOI
- Kanie, 2000, General Pharmacology: The Vascular System, 35, 311, 10.1016/S0306-3623(02)00115-5 · DOI
- Luscher, 1986, Hypertension, 8, 344, 10.1161/01.HYP.8.4.344 · DOI · Paper page
- Luscher, 1988, Hypertension, 11, 573, 10.1161/01.HYP.11.6.573 · DOI
- Diederich, 1990, Am J Physiol, 258, H445
- Bayat, 2008, Arterioscler Thromb Vasc Biol, 28, 127, 10.1161/ATVBAHA.107.150250 · DOI
- Zuccollo, 2005, Circulation, 112, 3001, 10.1161/CIRCULATIONAHA.105.581892 · DOI
- Xu, 2006, Diabetes, 55, 110, 10.2337/diabetes.55.01.06.db05-0831 · DOI · Paper page
- Wassmann, 2004, Hypertension, 44, 381, 10.1161/01.HYP.0000142232.29764.a7 · DOI · Paper page
- Redon, 2003, Hypertension, 41, 1096, 10.1161/01.HYP.0000068370.21009.38 · DOI · Paper page
- Tanito, 2004, Antioxid Redox Signal, 6, 89, 10.1089/152308604771978381 · DOI · Paper page
- Tagami, 1992, Metabolism, 41, 1053, 10.1016/0026-0495(92)90285-I · DOI
- Scheede-Bergdahl, 2005, Diabetes, 54, 3089, 10.2337/diabetes.54.11.3089 · DOI
- Zou, 1999, Am J Pathol, 154, 1359, 10.1016/S0002-9440(10)65390-4 · DOI · Paper page
- Schmidt, 2003, J Biol Chem, 278, 12813, 10.1074/jbc.M208080200 · DOI · Paper page
- Zou, 2002, Diabetes, 51, 198, 10.2337/diabetes.51.1.198 · DOI · Paper page
- Guo, 2003, Am J Physiol Heart Circ Physiol, 285, H1396, 10.1152/ajpheart.00096.2003 · DOI · Paper page
- Rosenthal, 2009, Journal of Biological Inorganic Chemistry, 14, 979, 10.1007/s00775-009-0550-4 · DOI
- Ying, 2008, Free Radic Biol Med, 45, 756, 10.1016/j.freeradbiomed.2008.05.029 · DOI
- Adachi, 2002, Circ Res, 90, 1114, 10.1161/01.RES.0000019757.57344.D5 · DOI · Paper page
- Beswick, 2001, Hypertension, 37, 781, 10.1161/01.HYP.37.2.781 · DOI · Paper page
- Hoffmann, 2008, Hypertension, 51, 1058, 10.1161/HYPERTENSIONAHA.107.107219 · DOI
- Jagadeesha, 2005, Am J Physiol Heart Circ Physiol, 289, H1047, 10.1152/ajpheart.01071.2004 · DOI
- Trujillo, 2008, Am J Physiol Renal Physiol, 295, F1574, 10.1152/ajprenal.90385.2008 · DOI
- DeRubertis, 2004, Diabetes, 53, 762, 10.2337/diabetes.53.3.762 · DOI · Paper page
- Ting, 1996, J Clin Invest, 97, 22, 10.1172/JCI118394 · DOI · Paper page
- Ting, 1996, Circulation, 94, I
- Plotnick, 1997, JAMA, 278, 1682, 10.1001/jama.1997.03550200058032 · DOI · Paper page
- Farmer, 2003, Am J Cardiol, 92, 3, 10.1016/S0002-9149(03)00503-4 · DOI
- Keli, 1996, Arch Intern Med, 154, 637, 10.1001/archinte.1996.00440060059007 · DOI · Paper page
- Leng, 1997, Vascular Medicine, 2, 279, 10.1177/1358863X9700200401 · DOI
- de Aguiar, 2006, Diabetes Care, 29, 1083, 10.2337/dc05-2146 · DOI · Paper page
- Rueckschloss, 2001, Circulation, 104, 1767, 10.1161/hc4001.097056 · DOI · Paper page
- Sumi, 2001, Atherosclerosis, 155, 347, 10.1016/S0021-9150(00)00597-9 · DOI
- Wagner, 2002, Arterioscler Thromb Vasc Biol, 20, 61, 10.1161/01.ATV.20.1.61 · DOI · Paper page
- Virdis, 2009, Hypertension, 53, 1008, 10.1161/HYPERTENSIONAHA.109.132258 · DOI
- Virdis, 2009, Hypertension, 53, 1008, 10.1161/HYPERTENSIONAHA.109.132258 · DOI
- Cayatte, 2000, Arterioscler Thromb Vasc Biol, 20, 1724, 10.1161/01.ATV.20.7.1724 · DOI · Paper page
- Zang, 2006, Diabetes, 55, 2180, 10.2337/db05-1188 · DOI · Paper page
- Cayatte, 2001, Arterioscler Thromb Vasc Biol, 21, 1577, 10.1161/hq1001.096723 · DOI · Paper page
Cited by
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
“Although arterial hypertension has been associated with oxidative stress and vascular in fl ammation (63), arterial hypertension is usually perceived to induce HFPEF through myocardial afterload excess (64).”
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“…such as hypertension, insulin resistance, and diabetes, lead to vascular oxidative stress and inflammation, both in animal models and in humans (Cohen and Tong, 2010; Iadecola and Davisson, 2008; Yates et al., 2012), which, in turn, impair the factors regulating the cerebral circulation…”
Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus
Shenouda, S. M., Widlansky, M. E., Chen, K., Xu, G., Holbrook, M., Tabit, C. E., Hamburg, N. M., Frame, A. A., Caiano, T. L., Kluge, M. A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.014506 · Cited by 570
Metadata
- Authors
- Cohen, R. A., & Tong, X.
- Venue
- Journal of Cardiovascular Pharmacology
- Published
- 2010-04
- Volume
- 55
- Issue
- 4
- Pages
- 308-316
- ISSN
- 0160-2446 (ISSN-L)
- OpenAlex
- W2005457857
- Cited by
- 125
- References
- 23
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vascular Oxidative Stress: The Common Link in Hypertensive and Diabetic Vascular Disease. https://app.cochat.ai/papers/10.1097/fjc.0b013e3181d89670
- The paper
- Cohen, R. A., & Tong, X. (2010). Vascular Oxidative Stress: The Common Link in Hypertensive and Diabetic Vascular Disease. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/fjc.0b013e3181d89670
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.